BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2015
View Archived Issues
Targeting Leishmania PEPCK protects mice from parasite challenge
Read More
AstraZeneca starts phase I study of MEDI-7352 in patients with osteoarthritis
Read More
Researchers present long-term survival data on AVX-701 cancer vaccine
Read More
Complexa completes four phase I studies of CXA-10 and plans phase II program
Read More
Arch Biopartners' AB-569 receives FDA orphan drug designation
Read More
Juniper Pharmaceuticals discloses new intravaginal ring candidates
Read More
DBV initiates phase IIa study of Viaskin Milk for milk-induced eosinophilic esophagitis
Read More
Novartis discloses vaccine adjuvants
Read More
Pharmascience presents new BTK inhibitor
Read More
Phase I data for biosimilar adalimumab, BI-695501
Read More
WNT-974, a first-in-class porcupine inhibitor in advanced solid tumors
Read More
Otsuka's OPB-111077 tested in subjects with advanced cancer
Read More
Nimbus' potent TYK2 inhibitor NDI-031301
Read More
Tesaro launches Varubi in the U.S.
Read More
Array BioPharma and Pierre Fabre collaborate on two novel oncology products
Read More
Promising results of a novel therapeutic approach to polycystic ovary syndrome
Read More
Starpharma's targeted DEP shows promise in ovarian cancer model
Read More
Protagen and Mikrogen agree on codevelopment program for Lyme disease diagnostic assay
Read More
Allergan reports interim data for bimatoprost sustained-release implant
Read More
Majority of Perrigo shareholders reject Mylan tender offer
Read More
Protalix plans phase III trials of PRX-102 for Fabry disease
Read More
FDA first to approve Darzalex for multiple myeloma
Read More
Otonomy initiates clinical development of OTO-311 for tinnitus
Read More
Masaryk University discloses protein kinase inhibitors
Read More
Dana-Farber Cancer Institute reports JAK3 inhibitors
Read More
Clovis provides FDA with requested clinical data on rociletinib
Read More
FDA accepts BMS's sBLA for nivolumab in RCC
Read More